本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2026/10/221 分钟阅读
HanchorBio and Aston Sci Join Forces to Unlock the Potential of Next-Generation Immunotherapy Through Cancer Vaccine Combinations
本地自动翻译 · 来源原始语言
摘要
Strategic collaboration pairs HCB101 (macrophage CD47-SIRPα blockade) with Aston Sci's Phase 2 HER2-directed DNA vaccine (AST-301) to drive durable, dual innate/adaptive antitumor immunity Initial studies focus on gas…
来源原始语言: PR Newswire — Global News Releases打开原始公告 →